Symmons, Deborah P M <br/><br/>
Anti-tumor necrosis factor alpha therapy and the risk of lymphoma in rheumatoid arthritis: no clear answer.  [electronic resource] 

 -  Arthritis and rheumatism  Jun 2004 
 - 1703-6 p.  digital 
<br/><br/> Publication Type: Comment; Editorial; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>0004-3591 
<br/><br/><label>Standard No.: </label>10.1002/art.20312  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Rheumatoid--drug therapy<br/>Humans<br/>Lymphoma--epidemiology<br/>Risk Factors<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors